MODULATION OF 2'5' OLIGOADENYLATE SYNTHETASE (2,5A)ACTIVITY AND INTERFERON (IFN) BINDING IN PATIENTS (PTS) WITH CHRONIC MYELOGENOUS LEUKEMIA (CML) UNDERGOING IFN THERAPY

被引：0
|
作者：
ROSENBLUM, MG [1 ]
MAXWELL, BL [1 ]
TALPAZ, M [1 ]
GUTTERMAN, JU [1 ]
机构：
[1] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,HOUSTON,TX 77030
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1984年 / 25卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：230 / 230
页数：1
相关论文
共 50 条
  • [31] Nilotinib (NIL) vs. NIL Plus Pegylated Interferon alpha2B (IFN) Induction and NIL or IFN Maintenance Therapy for Newly Diagnosed BCR-ABL1+Chronic Myeloid Leukemia (CML) Patients (PTS) in Chronic Phase
    Ernst, Thomas
    Saussele, Susanne
    Burchert, Andreas
    Baerlocher, Gabriela Maria
    Bruemmendorf, Tim Henrik
    La Rosee, Paul Graf
    Heim, Dominik
    Krause, Stefan W.
    Le Coutre, Philipp
    Niederwieser, Dietger
    Lange, Thoralf
    Haenel, Mathias
    Stegelmann, Frank
    Manz, Kirsi
    Himsel, Danny
    Hehlmann, Ruediger
    Fabisch, Christian
    Pfirrmann, Markus
    Hochhaus, Andreas
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 104 - 104
  • [32] Interferon-α lymphoblastoid in chronic myeloid leukemia patients unresponsive to recombinant IFNα2
    Steegmann, JL
    Granados, E
    Peñarrubia, MJ
    HAEMATOLOGICA, 1997, 82 (06) : 731 - 732
  • [33] INTERFERON THERAPY ON CHRONIC VIRAL-HEPATITIS AND PERIPHERAL LYMPHOCYTIC 2',5' -OLIGOADENYLATE SYNTHETASE ACTIVITIES
    FUJISAWA, K
    YAMAZAKI, K
    KAWASE, H
    OGURA, K
    KAMEDA, H
    JOURNAL OF MEDICAL VIROLOGY, 1987, 21 (04) : A129 - A129
  • [34] INTERFERON THERAPY AND THE RESPONSE OF LYMPHOCYTIC 2',5'-OLIGOADENYLATE SYNTHETASE IN HEPATITIS BE ANTIGEN POSITIVE CHRONIC HEPATITIS
    FUKUZAWA, K
    KAWASE, H
    OGURA, K
    FUJISAWA, K
    KAMEDA, H
    HEPATOLOGY, 1984, 4 (04) : 788 - 788
  • [35] Sustained response to interferon treatment in chronic hepatitis C is related to 2',5' oligoadenylate synthetase activity
    Chousterman, S
    Haddad, J
    Hagege, H
    Lons, T
    Gachet, Y
    Elharrar, B
    Chousterman, M
    GASTROENTEROLOGY, 1997, 112 (04) : A1243 - A1243
  • [36] INTERFERON THERAPY OF HBEAG POSITIVE CHRONIC HEPATITIS - ITS EFFICACY EVALUATED BY LYMPHOCYTIC 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY
    FUJISAWA, K
    YAMAZAKI, K
    KAWASE, H
    KAMEDA, H
    HEPATOLOGY, 1986, 6 (04) : 795 - 795
  • [37] INTERFERON THERAPY (REC-IFN-ALPHA-2C) IN CHRONIC MYELOID-LEUKEMIA
    KUHRER, I
    LINKESCH, W
    LUDWIG, H
    GISSLINGER, H
    ONKOLOGIE, 1987, 10 (05): : 281 - 281
  • [38] Sustained molecular responses with interferon α2a maintenance therapy after imatinib plus IFN induction treatment for chronic phase chronic myelogenous leukemia
    Hochhaus, Andreas
    Neubauer, Andreas
    Mueller, Martin C.
    Napieralski, Simone
    Erben, Philipp
    Bostel, Tilmar
    Hehlmann, Ruediger
    Burchert, Andreas
    BLOOD, 2007, 110 (11) : 16A - 17A
  • [39] COMBINED EFFECTS OF INTERFERON AND STEROID-HORMONES ON 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA CELLS
    TRIOZZI, PL
    AVERY, KB
    ABOUISSA, HM
    CHOU, TC
    LEUKEMIA RESEARCH, 1989, 13 (06) : 437 - 443
  • [40] COMBINED EFFECTS OF INTERFERON (INF) AND HORMONES ON 2',5'-OLIGOADENYLATE SYNTHETASE (OAS) ACTIVITY IN CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) CELLS
    TRIOZZI, P
    AVERY, K
    ISSA, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 244 - 244
12345